Syntegon Launched European Contamination Roadshow
The company has initiated a mobile tour across Europe to assist manufacturers with new sterile production regulations.
Updated on Oct. 12, 2026 in Consumer Goods
Live Poll
Do you trust that manufacturers are prioritizing patient safety standards as they implement new regulatory requirements?
Syntegon has launched a specialized roadshow featuring live demonstrations and consultations to help manufacturers adapt to revised EU GMP Annex 1 requirements. The mobile initiative utilizes a dedicated truck to bring contamination control technologies directly to customer sites across Europe.
Why it matters
Manufacturers are currently navigating stricter industry mandates that require documented contamination control strategies and advanced risk management for all sterile medicinal product production. This roadshow provides the technical support needed to ensure compliance with these updated regulatory standards.
The EU GMP Annex 1 revisions have been fully applicable since August 25, 2024, mandating comprehensive contamination control and risk management strategies. Compliance remains a critical operational priority for all manufacturers of sterile medicinal products.
The players
Syntegon
Syntegon is a global supplier of processing and packaging technology for the pharmaceutical and food industries.
The details
The tour showcases specialized hardware including an SPC settle plate changer, integrated glove testers, and PUPSIT filter test racks designed to minimize operator intervention. Engineering and service teams provide on-site consultations to help facilities implement these automated systems.
Timeline
The revised EU GMP Annex 1 became fully applicable on 25 August 2024.
The roadshow began at a site in Germany in late September 2026.
The roadshow will continue visiting customer sites across Europe through April 2027.
Market Landscape
This initiative follows a pattern set by the EU GMP Annex 1 regulatory framework which has forced a significant industry-wide pivot toward automated sterility solutions. Syntegon is positioning its hardware suite to capture market share among firms struggling to update legacy production lines.
Manufacturers can expect more direct access to technical support teams as the mobile unit visits facilities to demonstrate automated set-up tools. These onsite consultations help businesses streamline their compliance efforts and reduce the risk of production shutdowns due to regulatory gaps.
The takeaway
Companies should prioritize reviewing their current sterile production protocols against the updated EU GMP Annex 1 standards to identify specific equipment upgrade needs. Leveraging mobile technical consultations can help prevent costly disruptions to manufacturing workflows.
Further reading
Learn more about the latest innovations in Consumer Goods.
Source note: This article includes information reported by Manufacturingchemist.
Live Poll
Do you trust that manufacturers are prioritizing patient safety standards as they implement new regulatory requirements?
